Peptide Receptors, Part I

by ; ;
Edition: 1st
Format: Hardcover
Pub. Date: 2000-06-08
Publisher(s): Elsevier Science
  • Complimentary 7-Day eTextbook Access - Read more
    When you rent or buy this book, you will receive complimentary 7-day online access to the eTextbook version from your PC, Mac, tablet, or smartphone. Feature not included on Marketplace Items.
List Price: $265.00

Buy New

Usually Ships in 8 - 10 Business Days.
$264.74

Rent Textbook

Select for Price
There was a problem. Please try again later.

Rent Digital

Rent Digital Options
Online:1825 Days access
Downloadable:Lifetime Access
$378.00
*To support the delivery of the digital material to you, a digital delivery fee of $3.99 will be charged on each digital item.
$378.00*

Used Textbook

We're Sorry
Sold Out

How Marketplace Works:

  • This item is offered by an independent seller and not shipped from our warehouse
  • Item details like edition and cover design may differ from our description; see seller's comments before ordering.
  • Sellers much confirm and ship within two business days; otherwise, the order will be cancelled and refunded.
  • Marketplace purchases cannot be returned to eCampus.com. Contact the seller directly for inquiries; if no response within two days, contact customer service.
  • Additional shipping costs apply to Marketplace purchases. Review shipping costs at checkout.

Summary

During the last few years, the pace of research in the field of neuropeptide receptors has increased steadily: new neuropeptides were discovered, and the classification of receptor subtypes has been refined. It thus appeared essential to update the information. Peptide Receptors Part I summarizes current knowledge on ten distinct peptide families. This volume integrates photomontages and maps of quantitative receptor autoradiography, in situ hybridization histochemistry, and immunocytochemistry images. Application of these classical techniques and of new approaches such as transgenic and knock-out animals has revealed a distinct species and tissue specific variation in receptor subtypes expression and pharmacology in the mammalian central nervous system. The functional role of neuropeptides and their receptors in the CNS has been investigated thanks to the development of potent and selective receptor antagonists and agonists. The development of specific neuropeptide-related molecules will help to get a better understanding of receptor subtype physiology and neuronal distribution and may lead to innovative treatments in a variety of brain disorders.

Table of Contents

List of Contributors
v
Preface ix
Somatostatin Receptors
P. Dournaud
A. Slama
A. Beaudet
J. Epelbaum
Introduction
1(4)
Structural and biochemical properties
5(1)
Localization of somatostatin binding sites in the central nervous system
6(4)
Localization of somatostatin receptor subtypes
10(23)
sst1 receptor
10(1)
mRNA
10(4)
Protein
14(1)
sst2 receptor
15(1)
mRNA
15(2)
Protein
17(10)
sst3 receptor
27(1)
mRNA
27(1)
Protein
28(1)
sst4 receptor
28(1)
mRNA
28(1)
Protein
29(1)
sst5 receptor
30(1)
mRNA
30(1)
Protein
30(3)
Somatostatin receptors in brain disorders
33(1)
Brain tumors
33(1)
Alzheimer's disease
33(1)
Epilepsy
33(1)
Perspectives
34(1)
Abbreviations
34(1)
Acknowledgements
35(1)
References
36(9)
Brain PACAP/VIP Receptors: Regional Distribution, Functional Properties and Physiological Relevance
P. J. Magistretti
L. Journot
J. Bockaert
J.-L. Martin
Introduction
45(1)
Biosynthesis of VIP and PACAP
45(1)
VIP and PACAP binding sites
45(1)
Distribution of VIP and PACAP receptors
46(6)
Autoradiographic distribution of VIP binding sites in rodent brain
46(5)
Distribution of PACAP binding sites in rat brain
51(1)
Comparison between the distribution of VIP and PACAP binding sites
51(1)
Molecular cloning and pharmacological characterization of VIP/PACAP receptors
52(6)
VPAC1 and VPAC2: two genes, two receptors
52(1)
PAC1: one gene, seven receptors (at least)
53(1)
Pharmacology
54(2)
Distribution of VPAC1 and VPAC2 receptors in rat brain
56(1)
Distribution of PAC1 receptor mRNA
57(1)
Signal transduction
58(2)
VPAC1, VPAC2: two receptors, one effector
58(1)
PAC1: seven receptors, two effectors
58(1)
Agonist-directed PAC1 receptor trafficking of PLC stimulation
59(1)
Additional PAC1 receptor signal transduction
60(1)
Trophic actions of VIP and PACAP
60(2)
Neurotrophic actions elicited by VIP
60(1)
Stimulation of early embryonic growth by VIP
61(1)
VIP protects against excitotoxic cell death
61(1)
Neurotrophic and anti-apoptotic properties of PACAP
62(1)
Involvement of VIP/PACAP in circadian rhythms and sleep
62(1)
Involvement of VIP/PACAP in circadian rhythms
62(1)
VIP and PACAP are involved in sleep regulation
63(1)
Regulation of brain energy metabolism by VIP
63(2)
Regulation by VIP of genes controlling glycogen metabolism
64(1)
Glycogen synthase
64(1)
The C/EBP family of transcription factors
64(1)
Modulation by VIP and PACAP of glutamate-mediated signalling in the cerebral cortex
65(5)
VIP and PACAP potentiate the glutamate-evoked release of arachidonic acid
65(2)
VIP and PACAP potentiate the actions of glutamate on BDNF and c-fos expression
67(3)
Abbreviations
70(2)
Acknowledgements
72(1)
References
73(6)
Localization of Angiotensin Receptors in the Nervous System
A. M. Allen
B. J. Oldfield
M. E. Giles
G. Paxinos
M. J. McKinley
F. A. O. Mendelsohn
Introduction
79(3)
Renin--angiotensin system
79(1)
Renin--angiotensin system in the brain
79(1)
Actions of angiotensin in the brain
79(1)
Production of angiotensin in the brain
79(2)
Angiotensin receptors
81(1)
The AT1 receptor
81(1)
The AT2 receptor
81(1)
Other receptors of the angiotensin system
82(1)
The AT4 receptor
82(1)
Localization of AT1 and AT2 receptors
82(25)
Localization by autoradiography or hybridization histochemistry
83(4)
Distribution of AT1 and AT2 receptors in the rat brain
87(1)
Circumventricular organs
88(5)
Cerebral cortex
93(3)
Olfactory system
96(1)
Septum and hypothalamus
96(1)
Amygdala and bed nucleus of the stria terminalis
97(1)
Thalamus
97(1)
Basal ganglia
98(1)
The visual system
98(1)
Hippocampus
98(1)
Raphe nuclei
98(1)
Central gray
98(1)
Brainstem nuclei associated with cardiovascular, respiratory and other autonomic functions
99(1)
The auditory system
99(1)
The somatosensory system
99(1)
The pre-cerebellar and cerebellar nuclei
100(1)
Cervical spinal cord
100(1)
Immunohistochemical detection of AT1 receptors
100(1)
Distribution of AT1 receptor immunoreactivity in the rat brain
100(5)
The distribution of AT1 and AT2 receptors in other species
105(1)
AT1 receptors
105(1)
Ascending dopaminergic neurons in the substantia nigra
105(2)
AT2 receptors
107(1)
Overview of AT1 receptor functions in selected brain regions
107(6)
The lamina terminalis
107(1)
Immediate early gene expression
107(2)
Functions
109(2)
Osmoregulatory functions
111(1)
The hypothalamic paraventricular nucleus
111(1)
Magnocellular neurons
111(1)
Parvocellular neurons
111(1)
The dorsal vagal complex
112(1)
Systemic effects
112(1)
Nucleus of the solitary tract
112(1)
Dorsal motor nucleus of vagus
112(1)
The ventrolateral medulla
113(1)
Conclusion
113(1)
Abbreviations
114(4)
Acknowledgements
118(1)
References
118(7)
Brain Endothelin and Natriuretic Peptide Receptors
J. M. Saavedra
A. M. De Oliveira
O. Johren
L. Tonelli
Why endothelin and natriuretic receptors?
125(1)
Brain endothelin receptors
125(8)
Endothelin
125(1)
Distribution of endothelins
125(1)
Endothelin receptors
126(1)
Quantification of endothelin receptors and their subtypes
126(1)
How many receptor subtypes?
126(1)
Distribution of ET receptors
127(1)
Binding studies
127(1)
Immunocytochemical studies
127(3)
In situ hybridization studies
130(2)
Signal transduction mechanisms
132(1)
Functions of endothelin receptors in the brain
132(1)
Brain natriuretic peptide receptors
133(20)
Natriuretic peptides
133(2)
Distribution of natriuretic peptides in the brain
135(1)
Natriuretic peptide receptors
136(1)
Quantification of natriuretic peptide receptors and their subtypes
137(1)
How many receptor subtypes?
137(1)
Distribution of natriuretic peptide receptors
138(1)
Binding studies
138(3)
In situ hybridization studies
141(5)
Comparative distribution of ANP immunoreactivity and ANP receptors
146(1)
Signal transduction mechanisms
147(1)
Functions of natriuretic peptide receptors in the brain
147(5)
Other effects in the CNS
152(1)
Interactions between natriuretic peptides, endothelin and angiotensin II
153(1)
References
153(10)
Neuropeptide FF Receptors
J.-M. Zajac
C. Gouarderes
Introduction
163(1)
Pharmacological activities of neuropeptide FF
163(2)
Neuropeptide FF as a neurotransmitter
165(1)
Release of neuropeptide FF
165(1)
Distribution of neuropeptide FF
165(1)
Distribution of neuropeptide FF-immunoreactivity in rat brain
165(1)
Neuropeptide FF in rat spinal cord
166(1)
Neuropeptide FF receptors
166(18)
Methodological considerations
166(1)
Biochemical characterization of [125I]1DMe on spinal cord sections
167(1)
Pharmacological specificity of [125I]1DMe binding
168(1)
Brain neuropeptide FF receptors, autoradiographic distribution
168(1)
Rhinencephalon
169(1)
Telencephalon
169(1)
Diencephalon
169(6)
Mesencephalon
175(5)
Rhombencephalon
180(2)
Myelencephalon
182(2)
Brain neuropeptide FF receptors in other species
184(2)
Neuropeptide FF receptors in rodents
184(1)
Neuropeptide FF receptors in lagomorphs
184(2)
Neuropeptide FF receptors in man
186(1)
Discussion
186(2)
Abbreviations
188(2)
Acknowledgements
190(1)
References
190(5)
Neurokinin Receptors in the CNS
A. Ribeiro-Da-Silva
A. L. McLeod
J. E. Krause
Introduction
195(1)
Discovery of the tachykinins
195(1)
Distribution of tachykinin-like immunoreactivity
196(1)
Physiological functions of tachykinins
197(1)
CNS neurokinin receptors
198(31)
Receptor types
198(2)
Methods of study
200(1)
Studies with radioactive ligands
200(1)
NK-1 receptor binding sites
200(1)
NK-2 receptor binding sites
201(1)
NK-3 receptor binding sites
201(1)
In situ hybridization studies
201(1)
NK-1 receptor
201(1)
NK-2 receptor
202(1)
NK-3 receptor
202(1)
Immunocytochemical studies
202(1)
NK-1 receptor
203(2)
Methods
205(1)
Results
205(20)
Confocal and ultrastructural studies
225(3)
NK-2 receptor
228(1)
NK-3 receptor
228(1)
Are tachykinins mostly involved in `volume' transmission?
229(3)
Conclusion
232(1)
Abbreviations
232(2)
Acknowledgements
234(1)
References
234(7)
Brain Kallikrein-Kinin System: From Receptors to Neuronal Pathways and Physiological Functions
R. Couture
C. J. Lindsey
Introduction
241(1)
The kallikrein--kinin system
242(7)
Kinin receptors
243(4)
Signal transduction pathways
247(1)
Metabolic pathways
247(2)
Regional distribution of the kallikrein-kinin system in the central nervous system
249(13)
Kinin precursors (kininogens)
249(1)
Kinin synthesizing enzymes (kininogenases)
249(2)
Active molecules (kinins)
251(6)
Kinin degrading enzymes (kininases)
257(4)
Kinin receptors
261(1)
On the physiological role for kinins in central cardiovascular regulation
262(12)
Mechanisms subserving the cardiovascular effects of kinins in the CNS
262(4)
Site of action for cardiovascular effects of kinins in the CNS
266(5)
Receptors mediating the cardiovascular effects of kinins in the CNS
271(2)
Endogenous kinins in central control of blood pressure
273(1)
On the physiological role for kinins in the spinal cord
274(5)
Other central effects of kinins
279(4)
Considerations and perspectives
283(3)
Conclusion
286(1)
Abbreviations
287(1)
Acknowledgements
288(1)
References
288(13)
Calcitonin Gene-Related Peptide (CGRP), Amylin and Adrenomedullin: Anatomical Localization and Biological Functions in the Mammalian and Human Brains
D. Jacques
Y. Dumont
D. Van Rossum
R. Quirion
Discovery and genomic composition
301(3)
Structure of CGRP and structure--activity relationships
304(1)
Amylin
305(1)
Adrenomedullin
306(1)
Neuroanatomical localization
307(28)
CGRP mRNA containing neurons
307(1)
CGRP-like immunoreactivity in the brain
308(1)
CGRP-immunoreactive cell bodies
308(6)
CGRP-immunoreactive fibers
314(1)
Apparent mismatches
314(2)
Amylin-like immunoreactivity in the brain
316(1)
Adrenomedullin-like immunoreactivity in the brain
317(1)
Receptor distribution and characterization
317(1)
CGRP receptors
317(1)
Telencephalic CGRP binding sites
317(3)
Diencephalic CGRP binding sites
320(1)
Mesencephalic CGRP binding sites
321(1)
Pontine CGRP binding sites
322(1)
Cerebellar CGRP binding sites
323(1)
Myelencephalic CGRP binding sites
323(1)
Spinal CGRP binding sites
323(1)
CGRP-like immunoreactivity and binding sites in the human brain
323(2)
Mismatches
325(2)
CGRP receptor subtypes
327(4)
Calcitonin receptors
331(1)
Amylin binding sites in the brain
332(1)
Adrenomedullin receptors
332(1)
Separate receptors for CGRP, amylin and ADM?
333(2)
Biological activities
335(18)
Fiber pathways containing CGRP
335(1)
CGRP and olfaction
335(1)
CGRP and audition
336(1)
CGRP and vision
337(1)
CGRP and learning behaviors
337(1)
CGRP and taste and feeding
338(1)
CGRP and autonomic functions
339(1)
CGRP-induced behavioral changes
340(1)
CGRP and motoneurons: development and functions
341(2)
CGRP and sensory neurons
343(2)
CGRP and opioids
345(1)
CGRP effects in the cardiovascular system
346(2)
CGRP effects in the gastrointestinal tract
348(1)
Central and peripheral effects of amylin
349(2)
Central and peripheral effects of adrenomedullin
351(2)
Conclusion and perspectives
353(1)
Abbreviations
353(3)
Acknowledgements
356(1)
References
356(19)
Neuropeptide Y, Peptide YY and Pancreatic Polypeptide Receptor Proteins and mRNAs in Mammalian Brains
Y. Dumont
D. Jacques
J.-A. St-Pierre
Y. Tong
R. Parker
H. Herzog
R. Quirion
Introduction
375(2)
Biological effects of NPY and related peptides
377(1)
NPY, PYY and PP receptor subtypes
378(4)
The Y1 and Y2 receptor subtypes
378(2)
The Y4 receptor subtype
380(1)
The Y5 receptor subtype
381(1)
The Y6 receptor subtype
381(1)
The `so-called' Y3 receptor subtype
382(1)
Other NPY receptor subtypes?
382(1)
Agonists and antagonists of the NPY family
382(4)
Agonists
382(2)
Antagonists
384(1)
The Y1 antagonists
384(1)
The Y2 antagonists
385(1)
The Y5 antagonists
385(1)
NPY receptors in the rat brain
386(35)
Characterization of NPY receptors in the rat brain
386(3)
NPY receptor mRNAs
389(4)
Distribution of NPY receptor subtypes in rat brain
393(3)
Rhinencephalon
396(1)
Distribution of the Y1 receptor subtype
396(1)
Distribution of the Y2 receptor subtype
396(1)
Distribution of the Y4 receptor subtype
396(5)
Distribution of the Y5 receptor subtype
401(1)
Distribution and expression of the Y1, Y2, Y4 and Y5 receptor mRNA
401(1)
Telencephalon
402(1)
Distribution of the Y1 receptor subtype
402(1)
Distribution of the Y2 receptor subtype
402(8)
Distribution of the Y4 receptor subtype
410(1)
Distribution of the Y5 receptor subtype
410(1)
Distribution and expression of the Y1, Y2, Y4 and Y5 receptor mRNA
411(1)
Diencephalon
411(1)
Distribution of the Y1 receptor subtype
411(1)
Distribution of the Y2 receptor subtype
412(1)
Distribution of the Y4 receptor subtype
412(1)
Distribution of the Y5 receptor subtype
412(1)
Distribution and expression of the Y1, Y2, Y4 and Y5 receptor mRNA
413(1)
Mesencephalon
413(1)
Distribution of the Y1 receptor subtype
413(1)
Distribution of the Y2 receptor subtype
413(1)
Distribution of the Y4 receptor subtype
414(1)
Distribution of the Y5 receptor subtype
414(1)
Distribution and expression of the Y1, Y2, Y4 and Y5 receptor mRNA
414(1)
Metencephalon
414(1)
Distribution of the Y1 receptor subtype
414(4)
Distribution of the Y2 receptor subtype
418(1)
Distribution of the Y4 receptor subtype
418(1)
Distribution of the Y5 receptor subtype
418(1)
Distribution and expression of the Y1, Y2, Y4 and Y5 receptor mRNA
418(1)
Myelencephalon
419(1)
Distribution of the Y1 receptor subtype
419(2)
Distribution of the Y2 receptor subtype
421(1)
Distribution of the Y4 receptor subtype
421(1)
Distribution of the Y5 receptor subtype
421(1)
Distribution and expression of the Y1, Y2, Y4 and Y5 receptor mRNA
421(1)
NPY receptor subtypes in other species
421(16)
Distribution of NPY receptor subtypes in the mouse brain
423(1)
Distribution of NPY receptor subtypes in the guinea-pig brain
423(2)
Distribution of NPY receptor subtypes in the marmoset monkey (Callitrix jacchus) brain
425(6)
Distribution of NPY receptor subtypes in the vervet monkey (Cercopithecus pygerythrus) brain
431(1)
Distribution of NPY-like immunoreactivity and NPY receptor subtypes in the human brain
431(6)
Interactions of NPY with various neuronal populations
437(5)
Rhinencephalic neurons
437(1)
Telencephalic neurons
437(2)
Diencephalic neurons
439(1)
Metencephalic neurons
440(1)
Myencephalic neurons
441(1)
Physiological and pathophysiological implications of NPY and its receptors
442(8)
Feeding behavior
442(2)
Locomotion
444(1)
Learning behaviors and aging
444(1)
Seizure and epilepsy
445(1)
Thermoregulation, neuroendocrine regulation and circadian rhythms
446(1)
Thermoregulation
446(1)
Neuroendocrine regulation
446(1)
Circadian rhythms
447(1)
Depression and anxiety
447(1)
Opioid withdrawal and alcoholism
448(1)
Cardiorespiratory function
449(1)
Nociception
449(1)
Non-neuronal effects of NPY-like peptides
450(1)
Conclusion
450(1)
Abbreviations
451(4)
Acknowledgements
455(1)
References
456(21)
Multiple Brain Corticotropin-Releasing Factor Receptors and Binding Protein
E. B. De Souza
D. E. Grigoriadis
Introduction and historical perspectives
477(1)
CRF family of peptides
477(2)
Amino acid sequence and structure of CRF
477(1)
Amino acid sequence and structure of urocortin
478(1)
Organization of the CRF gene and protein precursor
479(1)
Organization of the urocortin gene and protein precursor
479(1)
Neuroanatomy of the CRF family of peptides
479(3)
Distribution of CRF in the central nervous system
479(3)
Distribution of urocortin in the central nervous system
482(1)
CRF receptors and binding protein
482(23)
Molecular biology/receptor structure
482(1)
CRF1 receptors
482(1)
CRF2 receptors
483(2)
CRF receptor splice variants
485(1)
CRF-binding protein
485(1)
Pharmacological characteristics
486(1)
Ligand binding profile of CRF1 receptors
486(1)
Ligand binding profile of CRF2 receptors
486(1)
Ligand binding profile of CRF-BP
487(1)
Guanine nucleotide characteristics of CRF receptors
488(1)
Second messenger characteristics of CRF receptors
488(1)
Localization of ligand-binding domains of CRF receptors: chimera and mutational studies
489(1)
Localization and function of CRF receptors and binding protein
490(1)
CRF receptor subtype(s) in brain and pituitary gland
491(1)
Brain
491(8)
Pituitary gland
499(2)
CRF2 receptor splice variants
501(1)
CRF-binding protein in brain and pituitary gland
502(3)
Summary and conclusions
505(1)
Acknowledgements
505(1)
References
505(4)
Subject Index 509

An electronic version of this book is available through VitalSource.

This book is viewable on PC, Mac, iPhone, iPad, iPod Touch, and most smartphones.

By purchasing, you will be able to view this book online, as well as download it, for the chosen number of days.

Digital License

You are licensing a digital product for a set duration. Durations are set forth in the product description, with "Lifetime" typically meaning five (5) years of online access and permanent download to a supported device. All licenses are non-transferable.

More details can be found here.

A downloadable version of this book is available through the eCampus Reader or compatible Adobe readers.

Applications are available on iOS, Android, PC, Mac, and Windows Mobile platforms.

Please view the compatibility matrix prior to purchase.